These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6232045)

  • 1. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
    Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
    Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of important serum lipid fractions in chronic hemodialysis patients and following kidney transplantation].
    Luci V; Wichmann T; Giesselmann M; Koall W; Mampel E
    Z Gesamte Inn Med; 1983 Mar; 38(5):153-7. PubMed ID: 6344469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lipids in diminished kidney function, during hemodialysis and after kidney transplantation].
    Frey FJ; Mordasini RC; Schlumpf E; Marone C; Montandon A; Flury W; Riva G
    Schweiz Med Wochenschr; 1977 Sep; 107(36):1248-53. PubMed ID: 199937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved lipid profiles with bicarbonate dialysis.
    Ahmad S; Haas L; Pagel M; Sherrard D
    Proc Clin Dial Transplant Forum; 1980; 10():186-9. PubMed ID: 7346846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of 3-GS as an anticoagulant in hemodialysis: effects on serum lipoproteins].
    Averna MR; Picone F; Galione A; Montalto G; Rini G; Notarbartolo A
    Clin Ter; 1982 Jan; 100(1):35-9. PubMed ID: 7151368
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein fractions and antithrombin III consumption during clotting.
    Winter JH; Bennett B; McTaggart F; Douglas AS
    Thromb Haemost; 1982 Jun; 47(3):236-8. PubMed ID: 7112497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
    Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract]   [Full Text] [Related]  

  • 9. [HDL-cholesterol in chronic renal failure and renal transplant (author's transl)].
    Masdeu S; Rubiés-Prat J; Nubiola AR; Ras MR; Masana L
    Med Clin (Barc); 1981 Oct; 77(7):280-3. PubMed ID: 7033690
    [No Abstract]   [Full Text] [Related]  

  • 10. De novo development of hypercholesterolaemia and increased HDL-cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation.
    Kobayashi N; Okubo M; Marumo F
    Proc Eur Dial Transplant Assoc; 1983; 19():505-9. PubMed ID: 6410382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-density-lipoprotein and renal insufficiency (author's transl)].
    Graf H; Stummvoll HK; Müller MM
    Wien Klin Wochenschr; 1982 Jan; 94(2):39-41. PubMed ID: 7080495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HDL cholesterol and vascular risks in chronic renal insufficiency].
    Delavelle F; Trombert JC; Canarelli G
    J Urol Nephrol (Paris); 1979 Sep; 85(9):578-82. PubMed ID: 230362
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in serum lipid levels and the spectrum of individual fatty acids in patients with chronic renal failure on conservative and hemodialysis treatment and their relation to dietary protein intake].
    Orbetsova V; Simeonov P; Todorov K; Elazarova F
    Vutr Boles; 1985; 24(4):63-70. PubMed ID: 4072171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary risk in patients with endstage renal disease: interaction of hypertension with hyperlipidemia.
    Goldberg AP; Tindira C; Harter HR
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S257-61. PubMed ID: 6177969
    [No Abstract]   [Full Text] [Related]  

  • 15. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
    Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
    J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
    Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
    Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid relation ships in dialysis and renal transplant patients.
    Nicholls AJ; Cumming AM; Catto GR; Edward N; Engeset J
    Q J Med; 1981; 50(198):149-60. PubMed ID: 7029600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study.
    Mekki K; Bouchenak M; Remaoun M; Belleville JL
    Med Sci Monit; 2004 Aug; 10(8):CR439-46. PubMed ID: 15277993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
    Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
    ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.